The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Warfant 5 mg Tablets

Mercury Pharmaceuticals (Ireland) LtdPA0073/139/003

Main Information

Trade NameWarfant 5 mg Tablets
Active SubstancesWARFARIN SODIUM
Dosage FormTablet
Licence HolderMercury Pharmaceuticals (Ireland) Ltd
Licence NumberPA0073/139/003

Group Information

ATC CodeB01AA Vitamin K antagonists
B01AA03 warfarin


License statusAuthorised
Licence Issued17/10/1995
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back